Evidence map›Paper›PMID 25798621›Full record

ArticleThe Journal of clinical investigation2015

NOTCH reprograms mitochondrial metabolism for proinflammatory macrophage activation.

Jun Xu, Feng Chi, Tongsheng Guo, Vasu Punj, W N Paul Lee, Samuel W French, Hidekazu Tsukamoto

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical investigation, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 148 papers.

0numbers the graph read from it
0cells of the map it votes in
148citing papers in PubMed
10.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

148 citing papers in PubMed, 243 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. NOTCH Signaling Networks in Perivascular Adipose Tissue.Arteriosclerosis, thrombosis, and vascular biology · 2025
    Review
  17. Review
  18. Article
  19. Review
  20. Review

88 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Jun Xu
Feng Chi
Tongsheng Guo
Vasu Punj
W N Paul Lee
Samuel W French
Hidekazu Tsukamoto
University of Southern California · US302 Military Hospital of China · CNLos Angeles Biomedical Research Institute · USUCLA Medical Center · US

Funding

The Southernearch Center for ALPD and CirrhosisP50AA011999 · NIAAA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI ANNA S. GUKOVSKAYA · 1999 to 2026
$45.8M
USC RESEARCH CENTER FOR LIVER DISEASES: PILOT PROGRAMSP30DK048522 · NIDDK · UNIVERSITY OF SOUTHERN CALIFORNIA · PI STILES, BANGYAN · 1995 to 2020
$21.8M
NON-PARENCHYMAL LIVER CELL CORER24AA012885 · NIAAA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI TSUKAMOTO, HIDEKAZU · 2001 to 2025
$8.1M
Notch signaling in Nos2 activation and steatohepatitis by obesity and alcoholK01AA020524 · NIAAA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI XU, JUN · 2011 to 2015
$544k
Molecular Mechanisms of Stellate Cell Activation in Liver FibrosisI01BX001991 · VA · VA GREATER LOS ANGELES HEALTHCARE SYSTEM · PI HIDEKAZU TSUKAMOTO · 2014 to 2026
–
BLRD VA I01 BX001991NIAAA NIH HHS K01 AA020524NIAAA NIH HHS K01AA020524NIAAA NIH HHS P50 AA011999NIAAA NIH HHS P50AA011999NIAAA NIH HHS R24 AA012885NIAAA NIH HHS R24AA12885NIDDK NIH HHS DK048522-19NIDDK NIH HHS P30 DK048522
6 · The paper itself

Abstract

Metabolic reprogramming is implicated in macrophage activation, but the underlying mechanisms are poorly understood. Here, we demonstrate that the NOTCH1 pathway dictates activation of M1 phenotypes in isolated mouse hepatic macrophages (HMacs) and in a murine macrophage cell line by coupling transcriptional upregulation of M1 genes with metabolic upregulation of mitochondrial oxidative phosphorylation and ROS (mtROS) to augment induction of M1 genes. Enhanced mitochondrial glucose oxidation was achieved by increased recruitment of the NOTCH1 intracellular domain (NICD1) to nuclear and mitochondrial genes that encode respiratory chain components and by NOTCH-dependent induction of pyruvate dehydrogenase phosphatase 1 (Pdp1) expression, pyruvate dehydrogenase activity, and glucose flux to the TCA cycle. As such, inhibition of the NOTCH pathway or Pdp1 knockdown abrogated glucose oxidation, mtROS, and M1 gene expression. Conditional NOTCH1 deficiency in the myeloid lineage attenuated HMac M1 activation and inflammation in a murine model of alcoholic steatohepatitis and markedly reduced lethality following endotoxin-mediated fulminant hepatitis in mice. In vivo monocyte tracking further demonstrated the requirement of NOTCH1 for the migration of blood monocytes into the liver and subsequent M1 differentiation. Together, these results reveal that NOTCH1 promotes reprogramming of mitochondrial metabolism for M1 macrophage activation.

Indexed as

AnimalsCell LineElectron TransportEndotoxemiaFatty Liver, AlcoholicFeedback, PhysiologicalGene Expression RegulationGlucoseInflammationLiver Failure, AcuteMacrophage ActivationMaleMiceMice, Inbred C57BLMice, KnockoutMitochondriaGlucoseNitric OxideNotch1 protein, mousePyruvate Dehydrogenase ComplexPyruvate Dehydrogenase (Lipoamide)-PhosphataseReactive Oxygen SpeciesReceptor, Notch1

Identifiers

PMID25798621
PMCPMC4396469
OpenAlexW2103018087

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.